罗 扬,王文娜,徐兵河.乳腺导管原位癌伴早期浸润79例临床分析[J].中国肿瘤,2017,26(2):140-144.
乳腺导管原位癌伴早期浸润79例临床分析
Breast Ductal Carcimona in Situ with Early Invasion:Clinical Analysis of 79 Cases
投稿时间:2016-07-03  
DOI:10.11735/j.issn.1004-0242.2017.02.A013
中文关键词:  导管原位癌  早期浸润  预后  治疗
英文关键词:ductal carcioma in situ  early invasion  prognosis  treatment
基金项目:
作者单位
罗 扬 国家癌症中心/中国医学科学院北京协和医学院肿瘤医院 
王文娜 国家癌症中心/中国医学科学院北京协和医学院肿瘤医院 
徐兵河 国家癌症中心/中国医学科学院北京协和医学院肿瘤医院 
摘要点击次数: 2639
全文下载次数: 757
中文摘要:
      摘 要:[目的] 探讨乳腺导管原位癌伴早期浸润(DCIS-Ei)的临床特征和预后。[方法] 回顾性收集1999年1月至2005年12月收治的79例不伴腋窝淋巴结转移的乳腺DCIS-Ei患者的临床资料,应用单因素分析影响预后的因素。[结果] 中位随访时间为10.3年,3例患者出现乳腺癌相关复发(BCRR),包括1例区域淋巴结转移,1例同时出现区域淋巴结和远处转移,1例对侧原发乳腺癌。10年累积BCRR率为5.3%。单因素预后分析结果显示,病灶>5.0cm (P=0.004)和原位癌成分内分泌受体(HR)阴性(P=0.011)是显著增加BCRR的因素。 [结论] 乳腺DCIS-Ei的长期预后良好,很少出现BCRR,病灶>5.0cm和HR阴性者容易发生BCRR。
英文摘要:
      Abstract:[Purpose] To explore the clinical characteristics and prognosis of breast ductal carcinoma in situ with early invasion (DCIS-Ei) . [Methods] In this retrospective study,the clinical data of 79 DCIS-Ei patients with axillary node-negative were collected between January 1999 and December 2005. Univariate analysis was used to examine the prognostic factors. [Results] Median follow-up was 10.3 years,3 of the 79 patients had breast cancer-related recurrence(BCRR),with 1 case of regional nodal recurrence,1 case of concurrent regional nodal/distant recurrences,and 1 case of contralateral primary breast cancer. The 10-year cumulative BCRR rate was 5.3%. In univariate analysis,lesion size>5.0cm (P=0.004) and hormonal receptor(HR) negative of the in situ component(P=0.011) were significantly associated with an increased risk of BCRR. [Conclusions] DCIS-Ei has a favorable prognosis with few BCRR after a long period of follow-up. Those patients with lesion size>5.0cm and HR negative are more likely to have BCRR.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器